Lipe & Dalton’s Lam Research LRCX Stock Holding History

Lipe & Dalton’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-300	Closed	-$130K	–	97
2026 Q2	$130K	Buy	+300	New	+$91.1K	0.06%	77

Other funds holding LRCX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Lipe & Dalton's LRCX Position: Q3 2026 in Review

Lipe & Dalton sold out of Lam Research (LRCX) in Q3 2026, closing a stake of 300 shares — an estimated $130K sold.

Lipe & Dalton first reported a position in LRCX in Q2 2026 and held it in 1 quarter. The position peaked at $130K in Q2 2026. 1,326 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

Lipe & Dalton reported no remaining Lam Research position as of Q3 2026 after selling out during the quarter.
Lipe & Dalton sold 300 Lam Research shares in Q3 2026, an estimated $130K.
Lipe & Dalton first reported a position in Lam Research in Q2 2026 and held it in 1 quarter.
Lipe & Dalton's Lam Research position peaked at $130K in Q2 2026.
1,326 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Lipe & Dalton's 13F filing for Q3 2026, filed 15 Oct 2026.